Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02804113

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
  • ID3 Medical Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02804113
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02804113. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04-25 (actual); primary completion 2018-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery
Acronym
VMI-CFA
Condition
Peripheral Arterial Disease
Intervention (Device)
Supera Peripheral Stent System
Lead sponsor
ID3 Medical (class: other)

Record details

Record id
cardio:ct-nct02804113
Content hash
ba2ba28426f5d664e13844915aeed4ea251f29fc5f1b426f45d387e5c47f10da